Drug interactions
Alogliptin-metformin + Tranylcypromine
Severity: Moderate
Alogliptin-metformin and Tranylcypromine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
MAO inhibitors may enhance the glucose-lowering effect of antidiabetic drugs, which can cause hypoglycemia.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alogliptin-metformin and Tranylcypromine interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Alogliptin-metformin
Other interactions of Tranylcypromine
- 5-HTP + Tranylcypromine Contraindicated
Drug class
- Alogliptin-metformin
- Endocrine
- Tranylcypromine
- Central Nervous System
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
